The study identified rare loss-of-function and missense variants in CLCN6, a chloride channel gene, which were associated with lower diastolic BP (−3.3 mmHg) and a 28% reduction in hypertension risk (OR = 0.72). The gene discussed is CLCN6; the disease is hypertensive disorder.